# DESCRIPTION

## STATEMENT REGARDING FEDERALLY SPONSORED R&D

- disclose government rights

## BACKGROUND

### Field

- define field of synthetic biology

### Description of the Related Art

- motivate population control circuits

## SUMMARY

- disclose nucleic acid compositions
- describe first polynucleotide encoding first synthase
- describe second polynucleotide encoding second synthase
- describe third polynucleotide encoding transporter
- describe fourth polynucleotide encoding signal-binding protein
- describe fifth polynucleotide encoding first fusion protein
- describe sixth polynucleotide encoding second fusion protein
- describe seventh polynucleotide encoding third fusion protein
- describe payloads under control of orthogonal signal
- describe target protein modulating payload activity
- define CAR and TCR components
- describe antigen binding domain
- list tumor antigens
- describe transmembrane domain
- describe intracellular signaling domain
- list costimulatory domains
- describe leader peptide
- describe constant region and CDR4
- list payload protein activities
- describe nuclease and DNA modification activities
- describe other payload protein activities
- describe diagnostic agents
- summarize programmable nuclease
- describe nucleic acid composition
- introduce payload protein
- describe orthogonal signal
- explain recombinase-based permanent switch
- detail nucleic acid composition components
- describe stop cassette
- introduce recombinase
- describe first synthase
- describe second synthase
- introduce signal-binding protein
- describe plant hormone
- define pro-death proteins
- list pro-death protein combinations
- describe polynucleotide operability
- introduce tandem gene expression elements
- describe promoter functionality
- list ubiquitous promoters
- describe signal-binding protein functionality
- introduce transcript stabilization elements
- describe orthogonal signal functionality
- introduce synthetic protein circuit components
- describe composition embodiments
- describe cell population embodiments
- introduce therapeutic program
- describe cell population configuration
- detail cell population size and/or density control
- describe cell population oscillation
- describe modulation of cell population size and/or density
- describe cell population size and/or density threshold
- describe therapeutic program activation
- describe immune cell activation
- describe cell differentiation
- describe cell state switching
- describe synthetic organogenesis and/or tissue repair
- describe evolutionary robustness to mutations
- describe eukaryotic cell types
- describe stem cell types
- describe targeting moieties
- describe critical cell population size and/or density threshold
- describe targeting moieties binding
- outline treatment methods
- define target site of disease or disorder
- specify types of tissue
- describe disease associated with tumor antigen
- list various types of diseases or disorders
- describe method of administering additional agents
- specify types of additional agents
- list various types of chemotherapeutic agents
- describe anti-EGFR antibodies
- describe antimetabolites
- describe vinca alkaloids
- describe platinum-based agents
- describe anthracyclines
- describe topoisomerase inhibitors
- describe taxanes
- describe antibiotics
- describe immunomodulators
- describe various other types of agents

## DETAILED DESCRIPTION

- introduce detailed description
- reference to accompanying drawings
- define scope of disclosure
- incorporate patents and publications by reference
- describe nucleic acid compositions
- describe compositions and populations of cells
- describe methods for treating a disease or disorder

### Definitions

- define nucleic acid and polynucleotide
- define vector
- define construct
- define plasmid
- define element and regulatory element
- define promoter
- define enhancer
- define operably linked
- define subject
- define treatment
- define effective amount
- define pharmaceutically acceptable carriers

### Synthetic Mammalian Signaling Circuits for Robust Cell Population Control

- introduce synthetic mammalian signaling circuits
- describe quorum sensing system
- describe population control circuits
- describe orthogonal communication channels
- describe negative feedback circuit
- describe paradoxical regulatory architecture
- describe applications of circuits

### Circuit Components

- define nucleic acid compositions
- describe first polynucleotide encoding first synthase
- describe second polynucleotide encoding second synthase
- describe third polynucleotide encoding transporter
- describe fourth polynucleotide encoding signal-binding protein
- describe fifth polynucleotide encoding first fusion protein
- describe sixth polynucleotide encoding second fusion protein
- describe seventh polynucleotide encoding third fusion protein
- describe two or more nucleic acid compositions
- describe signal-binding protein binding orthogonal signal
- describe signal-binding protein reducing stability of protein
- describe fifth, sixth, and seventh polynucleotides operably linked to tandem gene expression element
- describe first promoter operably linked to fifth, sixth, and seventh polynucleotides
- describe first promoter inducing transcription of fifth, sixth, and seventh polynucleotides
- describe polycistronic transcript capable of being translated
- describe nucleic acid comprising at least one regulatory element
- describe vector for expression of synthetic protein circuit
- describe integrating and non-integrating vectors
- describe regulatory sequence allowing translation of multiple proteins
- describe expression control elements influencing expression of RNA and protein products
- describe tissue-specific expression control elements and promoters
- describe ubiquitous or promiscuous promoters and enhancers
- describe regulatable elements increasing or decreasing expression
- describe composition comprising one or more vectors

### Orthogonal Signals

- define orthogonal signal
- describe properties of orthogonal signal
- list examples of orthogonal signal molecules
- specify types of plant hormones

### Target Proteins & Payload Proteins

- define target protein and payload protein
- describe regulation of payload protein by target protein
- introduce protease and degron
- describe cage polypeptide and key polypeptide
- introduce synthetic protein circuit component
- describe payload protein activities
- introduce activity regulator
- describe activity regulator functions
- introduce prodrug-converting enzyme
- describe payload RNA agent
- introduce cytokine and other payload proteins
- define target proteins
- list therapeutic proteins
- describe active fragments
- describe fusion proteins
- describe multi-subunit proteins
- describe antibodies
- describe pro-survival proteins
- describe apoptotic factors
- describe cellular reprogramming factors
- describe programming factors
- describe human adjuvant proteins
- describe modifying nucleotide sequences
- describe expression levels
- describe payload gene lengths
- define target proteins & payload proteins
- describe chimeric antigen receptors (CARs) & engineered T cell receptors (TCRs)
- detail CAR structure & components
- explain intracellular signaling domains
- describe costimulatory molecules & domains
- outline primary & costimulatory intracellular signaling domains
- discuss CAR design with multiple costimulatory signaling domains
- describe linker molecules in CAR design
- list examples of costimulatory signaling domains
- explain antibody or antibody fragment forms in CARs
- describe single domain antibody fragments (sdAbs) & single chain antibodies (scFvs)
- discuss humanized & bispecific antibodies
- outline antigen binding domain forms in CARs
- explain target-specific binding elements in CARs
- define target proteins & payload proteins
- describe antigen binding domain
- list types of antigen binding domains
- describe T cell receptor as antigen binding domain
- describe bispecific antibody molecule
- describe tumor antigen
- list examples of tumor antigens
- describe solid tumor antigen
- describe tumor antigen selection
- describe antigen binding domain connection to transmembrane domain
- describe hinge region
- describe transmembrane domain
- describe transmembrane domain attachment
- describe transmembrane domain modification
- describe transmembrane domain homodimerization
- describe transmembrane domain interaction minimization
- list transmembrane domain sources
- describe transmembrane domain signaling

### Pro-Growth Proteins and Pro-Death Proteins

- define pro-growth proteins
- define pro-death proteins
- describe suicide genes and prodrugs

### Cell Populations

- define cell populations
- describe sender cells
- describe receiver cells
- describe sender-receiver cells
- explain orthogonal signal function
- describe cell population control
- explain therapeutic program activation
- describe cell state switching
- define cell populations
- describe cell population size and/or density control
- motivate therapeutic program activation
- describe immune cell activation
- describe cell differentiation
- describe cell state switching
- describe synthetic organogenesis and/or tissue repair
- describe evolutionary robustness to mutations
- describe eukaryotic cell types
- introduce targeting moieties
- describe targeting moieties binding to target site components
- describe local critical cell population size and/or density threshold
- list targeting moieties
- describe antibody or antigen-binding fragment thereof
- list target antigens
- describe targeting moieties binding to target antigens
- conclude targeting moieties

### Methods of Treating a Disease or Disorder

- introduce method for treating disease
- isolate cells from subject
- introduce nucleic acid composition into cells
- administer population of cells to subject
- specify diseases or disorders to be treated
- describe administration methods
- specify therapeutically effective amount of cells
- describe composition for therapy
- define target site
- describe tissue types
- specify engineered cell activation
- detail payload protein concentration ratio
- define target site and cells
- specify cell death ratios
- introduce method of treating disease or disorder
- administer additional agents to subject
- describe additional agents
- list alkylating agents
- list antimetabolites
- list vinca alkaloids
- list platinum-based agents
- list anthracyclines
- list topoisomerase inhibitors
- list taxanes
- list antibiotics
- list immunomodulators
- list other inhibitors

## EXAMPLES

- provide examples

### Example 1

- introduce synthetic mammalian quorum sensing circuits
- motivate population control in multicellular organisms
- describe limitations of existing intercellular communication systems
- introduce auxin as a private communication channel
- describe auxin's mechanism of action
- motivate the need for a paradoxical population control circuit
- introduce the Paradaux circuit
- describe the construction of the auxin-sensing Receiver cell line
- demonstrate auxin regulation of mammalian cell growth
- describe the construction of the auxin-producing Sender-Receiver cell line
- demonstrate auxin synthesis in mammalian cells
- estimate the spatial range of auxin signaling
- demonstrate quorum sensing in engineered cell lines
- introduce Paradaux cell line
- demonstrate density-dependent control of cell survival
- describe limitations of negative feedback circuit
- motivate paradoxical circuit architecture
- design paradoxical circuit
- encode Paradaux circuit
- test Paradaux circuit functionality
- develop mathematical model of Paradaux circuit
- identify parameter regimes for paradoxical control
- analyze model behavior
- experimentally analyze population control
- demonstrate robustness of paradoxical population control
- conclude effectiveness of paradoxical control circuit
- introduce paradoxical population control architecture
- describe time-lapse imaging experiment
- analyze fluorescence of mCherry and mGFP
- compare population control conditions
- discuss BlastR expression and phenotypic behavior
- analyze cell survival
- explain paradoxical architecture design
- perform RNA sequencing analysis
- analyze gene expression changes
- discuss negative feedback population control circuit
- describe time-lapse imaging of continuous culture
- analyze population dynamics and stability
- discuss appearance of cheater mutations
- analyze resistance mutations
- discuss paradoxical architecture and cheater mutants
- discuss natural cytokine-based control circuits
- describe synthetic population control circuits
- discuss auxin cell-cell communication system
- provide materials, methods, and supplementary text
- define paradoxical population control circuit model
- describe biochemical reactions and assumptions
- derive differential equations for iCasp9 and BlastR
- model blasticidin and AP1903 interactions
- describe overall population dynamics using generalized logistic function
- simplify model using singular perturbation theory
- define additional parameter combinations for simplicity
- represent synergy between iCasp9 and blasticidin control of cell survival
- perform parameter screening and stability analysis
- introduce experimental model and details
- describe tissue culture and cell lines
- outline method details
- explain gene constructs
- describe cell line engineering
- detail flow cytometry
- describe conditioned media
- outline cell imaging
- explain long-range gradient setup
- describe bulk RNA sequencing of isolates
- detail quantification and statistical analysis
- explain confluence estimation
- describe RNA-sequencing analysis
- outline bootstrapping and significant tests
- provide general statements on patent claims
- conclude with general statements on patent scope

